Shanghai Fudan Forward S&T Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Shanghai Fudan Forward S&T.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 18.9% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Revenues Not Telling The Story For Shanghai Fudan Forward S&T Co., Ltd (SHSE:600624) After Shares Rise 27%
Nov 25What Shanghai Fudan Forward S&T Co., Ltd's (SHSE:600624) 33% Share Price Gain Is Not Telling You
Oct 01Solid Earnings May Not Tell The Whole Story For Shanghai Fudan Forward S&T (SHSE:600624)
Sep 06What Shanghai Fudan Forward S&T Co., Ltd's (SHSE:600624) 32% Share Price Gain Is Not Telling You
Jul 24Some Confidence Is Lacking In Shanghai Fudan Forward S&T Co., Ltd (SHSE:600624) As Shares Slide 29%
Jun 06Shanghai Fudan Forward S&T Co., Ltd's (SHSE:600624) Share Price Could Signal Some Risk
Feb 27In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Shanghai Fudan Forward S&T has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 639 | -33 | -6 | -49 | N/A |
6/30/2024 | 649 | -11 | -62 | -55 | N/A |
3/31/2024 | 665 | -5 | -32 | -25 | N/A |
12/31/2023 | 680 | 6 | 0 | 7 | N/A |
9/30/2023 | 731 | -4 | -35 | 33 | N/A |
6/30/2023 | 765 | -9 | -26 | -5 | N/A |
3/31/2023 | 741 | -12 | -6 | 15 | N/A |
12/31/2022 | 789 | -6 | 7 | 28 | N/A |
9/30/2022 | 837 | -118 | -90 | -80 | N/A |
6/30/2022 | 919 | -110 | -1 | 15 | N/A |
3/31/2022 | 1,011 | -104 | 23 | 41 | N/A |
12/31/2021 | 1,041 | -105 | 19 | 46 | N/A |
9/30/2021 | 1,005 | -68 | 128 | 155 | N/A |
6/30/2021 | 994 | -62 | 129 | 154 | N/A |
3/31/2021 | 979 | -68 | 76 | 105 | N/A |
12/31/2020 | 940 | -60 | 39 | 59 | N/A |
9/30/2020 | 975 | 38 | 56 | 79 | N/A |
6/30/2020 | 986 | 37 | 33 | 52 | N/A |
3/31/2020 | 1,100 | 54 | 70 | 85 | N/A |
12/31/2019 | 1,400 | 56 | 5 | 19 | N/A |
9/30/2019 | 1,412 | 52 | -16 | -10 | N/A |
6/30/2019 | 1,406 | 52 | 17 | 26 | N/A |
3/31/2019 | 1,287 | 48 | 45 | 54 | N/A |
12/31/2018 | 1,008 | 43 | 111 | 126 | N/A |
9/30/2018 | 931 | 48 | 129 | 153 | N/A |
6/30/2018 | 854 | 44 | N/A | 150 | N/A |
3/31/2018 | 798 | 43 | N/A | 109 | N/A |
12/31/2017 | 736 | 42 | N/A | 96 | N/A |
9/30/2017 | 710 | 28 | N/A | 70 | N/A |
6/30/2017 | 701 | 33 | N/A | 14 | N/A |
3/31/2017 | 687 | 40 | N/A | -15 | N/A |
12/31/2016 | 671 | 38 | N/A | -26 | N/A |
9/30/2016 | 691 | 60 | N/A | -41 | N/A |
6/30/2016 | 676 | 57 | N/A | -43 | N/A |
3/31/2016 | 676 | 53 | N/A | -7 | N/A |
12/31/2015 | 718 | 52 | N/A | 70 | N/A |
9/30/2015 | 809 | 44 | N/A | 40 | N/A |
6/30/2015 | 891 | 42 | N/A | 79 | N/A |
3/31/2015 | 975 | 41 | N/A | 53 | N/A |
12/31/2014 | 1,008 | 41 | N/A | 36 | N/A |
9/30/2014 | 985 | 36 | N/A | 75 | N/A |
6/30/2014 | 987 | 35 | N/A | 89 | N/A |
3/31/2014 | 957 | 34 | N/A | -32 | N/A |
12/31/2013 | 952 | 34 | N/A | -133 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 600624's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if 600624's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 600624's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 600624's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 600624's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 600624's Return on Equity is forecast to be high in 3 years time